Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate

Urology

Volumn 61, Issue 6, 2003, Pages 1181-1186

  De La Taille, Alexandre ^a   Antiphon, Patrick ^b   Salomon, Laurent ^b   Cherfan, Maguy ^b   Porcher, Raphael ^b   Hoznek, Andras ^b   Saint, Fabien ^b   Vordos, Dimitri ^b   Cicco, Anthony ^b   Yiou, René ^b   Zafrani, Elie Serge ^b   Chopin, Dominique ^b   Abbou, Claude Clément ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PROSTATE SPECIFIC ANTIGEN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EVALUATION; FEVER; HEMATURIA; HEMOSPERMIA; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MORBIDITY; NEEDLE BIOPSY; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATITIS; QUESTIONNAIRE; RECTUM HEMORRHAGE; SAMPLE; SCORING SYSTEM; STATISTICAL ANALYSIS; TUMOR VOLUME; ULTRASOUND; URINE RETENTION; VISUAL ANALOG SCALE;

EID: 0037602167     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00108-0     Document Type: Article

References (23)

1. Hodge K.K., McNeal J.E., Stamey T.A. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol. 142:1989;66-70.
2. Norberg M., Egevad L., Holmberg L., et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 50:1997;562-566.
3. Stewart C.S., Leibovich B.C., Weaver A.L., et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 166:2001;86-92.
4. Liu I.J., Macy M., Lai Y.H., et al. Critical evaluation of the current indications for transition zone biopsies. Urology. 57:2001;1117-1120.
5. Ravery V., Goldblatt L., Royer B., et al. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol. 164:2000;393-396.
6. Eskew L.A., Bare R.L., McCullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 157:1997;199-203.
7. Presti J.C. Jr, Chang J.J., Bhargava V., et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies results of a prospective clinical trial . J Urol. 163:2000;163-167.
8. Chan T.Y., Chan D.Y., Stutzman K.L., et al. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? J Urol. 166:2001;2181-2184.
9. Gore J.L., Shariat S.F., Miles B.J., et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 165:2001;1554-1559.
10. Epstein J.I., Walsh P.C., Sauvageot J., et al. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol. 158:1997;1886-1890.
11. Babaian R.J., Toi A., Kamoi K., et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol. 163:2000;152-157.
12. Collins G.N., Lloyd S.N., Hehir M., et al. Multiple transrectal ultrasound-guided prostatic biopsies - true morbidity and patient acceptance. Br J Urol. 71:1993;460-463.
13. Rietbergen J.B., Kruger A.E., Kranse R., et al. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate evaluation of complication rates and risk factors within a population-based screening program . Urology. 49:1997;875-880.
14. Clements R., Aideyan O.U., Griffiths G.J., et al. Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol. 47:1993;125-126.
15. Enlund A.L., Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy a prospective study in 415 cases . Br J Urol. 79:1997;777-780.
16. Chang S.S., Alberts G., Wells N., et al. Intrarectal lidocaine during transrectal prostate biopsy results of a prospective double-blind randomized trial . J Urol. 166:2001;2178-2180.
17. Chen M.E., Troncoso P., Johnston D.A., et al. Optimization of prostate biopsy strategy using computer based analysis. J Urol. 158:1997;2168-2175.
18. Eskew L.A., Woodruff R.D., Bare R.L., et al. Prostate cancer diagnosed by the 5 region biopsy method is significant disease. J Urol. 160:1998;794-796.
19. Chang J.J., Shinohara K., Bhargava V., et al. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol. 160:1998;2111-2114.
20. Naughton C.K., Smith D.S., Humphrey P.A., et al. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores a retrospective study . Urology. 52:1998;808-813.
21. Epstein J.I., Walsh P.C., Carter H.B. Importance of posterolateral needle biopsies in the detection of prostate cancer. Urology. 57:2001;1112-1116.
22. Roehl K.A., Antenor J.A., Catalona W.J. Serial biopsy results in prostate cancer screening study. J Urol. 167:2002;2435-2439.
23. Letran J.L., Blase A.B., Loberiza F.R., et al. Repeat ultrasound guided prostate needle biopsy use of free-to-total prostate specific antigen ratio in predicting prostatic carcinoma . J Urol. 160:1998;426-429.